(845) 826-1651

Posts by Jack Teitelman

Filter Posts

Founded by retired DEA Supervisory Special Agent, Jack Teitelman, TITAN Group is a full-service regulatory compliance, drug security and anti-diversion solutions provider. TITAN’s team of experts have extensive law enforcement backgrounds at local, state and federal level which allows us to offer a full-suite of services from initial licensing to establishing robust procedures, security protocols, operating procedures, and training.

EMS Agencies and DEA Registrations: Hospitals? Med Directors? Confusion!

Let’s clear up the trickiest puzzler right from the start: EMS agencies that want to purchase and use controlled substances for patient care need a DEA registration. Just... Read More

Marijuana Mess: Moving to Schedule III and Compliance Chaos

For years, the cannabis industry has waited for federal reform. The recent move reclassifying medical cannabis from Schedule I to Schedule III under the Controlled Substances... Read More

What Happens After a DEA Inspection at a Veterinary Practice?

Understanding the Possible Outcomes and How to Protect Your DEA Registration When DEA Diversion Investigators arrive at your veterinary practice, you’ll probably focus on one... Read More

Power of Attorney: What It Is, Why It Matters, and How Veterinarians Get It Wrong

A Power of Attorney (POA) is one of the simplest — yet most commonly mishandled — documents in veterinary DEA compliance. When used properly, a POA allows a veterinarian who... Read More

Protecting Your Pharmacy from DEA Risk and Distributor Cut-Off

The compliance landscape for independent pharmacies has changed—and it’s getting tougher. Ongoing opioid litigation, enforcement actions, and increased scrutiny from the DEA... Read More

What DEA Manufacturing License Holders Must Know About Drug Diversion

Supply Chain Drug Diversion Prevention: What DEA Manufacturing License Holders Must Know The diversion of drugs remains one of the most serious risks within pharmaceutical... Read More

Blind Spots in Plain Sight: The Value of an Unbiased Compliance Review

How TITAN’s Third-Party Audits Help Facilities Stay Ahead An organization’s approach to regulatory compliance is often shaped by familiarity. Processes evolve, workarounds... Read More

Vets’ Biennial Inventory Blunders —And How to Avoid Them

TITAN Group’s DEA compliance experts – former DEA Diversion Investigators – saw countless violations of the Controlled Substance Act (CSA) during their many years of... Read More

The Drug Supply Chain Security Act Explained: What Pharmacies and Manufacturers Must Know

The pharmaceutical supply chain is under increasing scrutiny as regulators and industry leaders work to combat counterfeit drugs, diversion, and other vulnerabilities that... Read More

Medetomidine: What Pharmacies Must Do Now

Medetomidine: The Next Dangerous Threat in the Illicit Drug Supply & What Pharmacies Must Do Now The opioid crisis continues to evolve in ways that make it increasingly... Read More

The New DEA Reality for EMS: What Changed on March 9, 2026 — and What It Means for Your Agency

Effective March 9, 2026, EMS agencies officially became DEA registrants. Read More

Theft and Significant Loss of Controlled Substances - Understanding Federal and State Reporting Requirements

Controlled substances are tightly regulated because they carry a high potential for abuse, diversion, and misuse. When a theft or significant loss occurs, the risk to public... Read More

What Triggers a DEA Inspection? Key Factors Every Registrant Should Understand

A DEA inspection can feel intimidating, but in most cases, inspections don’t happen “out of the blue.” They’re usually triggered by internally identifiable signals, patterns,... Read More

February 5, 2026

How to Prevent Drug Diversion in Veterinary Practices: Compliance Strategies That Work

Drug diversion is a growing risk in veterinary clinics, where controlled substances such as opioids, sedatives, and anesthetics are routinely handled as part of patient care.... Read More

January 7, 2026

Drug Diversion in Pharmacy: 7 Warning Signs You Should Know

Drug diversion in pharmacy settings poses a serious and growing risk to patient safety, regulatory compliance, and organizational integrity. At its core, pharmacy diversion... Read More

1
2
3
4